Aug 2026· Frontiers in Immunology· Vol 17· 0 citations· 47 references
Medicine
TL;DR
Different vaccination regimens were associated with distinct long-term cellular immune profiles under real-world conditions, with both homologous BNT162b2 and heterologous CoronaVac/BNT162b2 vaccination regimens maintaining robust memory B cell signatures and functional recall responses.
Abstract
Introduction Understanding how different COVID-19 vaccine combinations shape long-term immunity is essential for improving durability and guiding booster strategies. Despite extensive characterization of neutralizing antibodies, long-term memory B and T cell responses after homologous and heterologous vaccination regimens remain poorly understood. Methods In this study, peripheral blood mononuclear cells (PBMCs) from 50 individuals were analyzed 12 months after completion of a homologous two-dose primary COVID-19 vaccination series and had received a single booster dose (12-month follow-up). Participants initially received BNT162b2, ChAdOx1 nCoV-19, or CoronaVac as the primary vaccination series, followed by either a homologous booster or a heterologous BNT162b2 booster (ChAdOx1 nCoV-19/BNT162b2 and CoronaVac/BNT162b2). Unvaccinated individuals served as controls. B cell phenotypes were assessed using flow cytometry, while B and T cell recall responses were determined using ELISpot. IgG levels and cytokine/chemokine/growth factor profiles were evaluated using ELISA and Bio-Plex multiplex before and after in vitro stimulation. Results The homologous BNT162b2 vaccination regimen exhibited significantly higher frequencies of memory B cells recognizing the ancestral (Wuhan strain-derived) SARS-CoV-2 Spike protein compared to the ChAdOx1 nCoV-19, CoronaVac, and unvaccinated controls. The CoronaVac/BNT162b2 vaccination regimen demonstrated significantly elevated RBD-specific IgG+ memory B cells and higher stimulated IgG levels, together with the highest IFN-γ-producing T cell responses. Homologous CoronaVac and CoronaVac/BNT162b2 vaccination regimens showed broader cytokine activation, including IL-6, IL-9, IL-15, TNF-α, and other cytokines. IL-6 levels were positively associated with memory B cell frequencies, suggesting a potential association with memory B cell differentiation and maintenance. Discussion Different vaccination regimens were associated with distinct long-term cellular immune profiles under real-world conditions, with both homologous BNT162b2 and heterologous CoronaVac/BNT162b2 vaccination regimens maintaining robust memory B cell signatures and functional recall responses. The results highlight how priming combinations shape the durability and quality of immune memory, supporting the potential utility of mixed-platform booster strategies for sustaining long-term immunity.
A BNT162b2 booster following diverse primary COVID-19 vaccination regimens induced strong humoral responses that declined over 12 months and showed an acceptable reactogenicity profile.
Despite the significant impact of SARS-CoV-2 vaccines in curtailing the spread and severity of COVID-19, comprehensive omics-level understanding of longitudinal host responses remains elusive. We recruited 553 Hong Kong participants receiving two doses of CoronaVac (inactivated virus) or BNT162b2 (mRNA-based). Longit...
H. Tun, Shi-Lin Zhao, Chun-Ke Chen et al.· Cellular and Molecular Life...· 0 citations
Nucleic acid vaccines offer rapid and flexible platforms for addressing infectious diseases but achieving durable and balanced immunity remains a challenge. We evaluated a closed linear synthetic Doggybone™ DNA vaccine (dbDNA™) encoding influenza A/California/07/2009 hemagglutinin across delivery platforms and preclini...
Helen Horton, Robert F. Cunliffe, Sungwon Kim et al.· Molecular Therapy· 0 citations
SARS-CoV-2 Spike protein evolution compromises sustained efficacy of existing vaccines based on neutralizing antibodies. Here we show that OVX033, a nucleocapsid (NCAP)-based vaccine candidate engineered with the self-assembling oligoDOM™ domain, induces robust cellular immunity in two preclinical models. In hamste...
R. Marlin, C. Primard, Anne-Sophie Gallouët et al.· Communications Biology· 0 citations
Although mRNA-based COVID-19 vaccines have demonstrated high efficacy, their widespread global use remains constrained by high production costs and cold-chain requirements. Modified vaccinia virus Ankara (MVA) is a highly attenuated and thermostable viral vector with low production costs, potent immunogenicity, and str...
Patricia Pérez, G. Esteso, Isabel García-García et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.